Skip to main content
. Author manuscript; available in PMC: 2018 Aug 15.
Published in final edited form as: Cancer Res. 2017 Jun 23;77(16):4486–4497. doi: 10.1158/0008-5472.CAN-16-2643

Figure 3. The Nf1 haploinsufficient bone marrow compartment is sufficient to accelerate MPNST formation.

Figure 3

(A) Schematic of bone marrow transplant. Recipient mice were all NIF/F and received either NIF/F or NIF/− bone marrow containing a fluorescent reporter. After 4 weeks of recovery, the mice were injected with Ad-Cre into the sciatic nerve and monitored for MPNST development. (B). Mice that received NIF/− bone marrow developed MPNST earlier than mice that received NIF/F bone marrow. (C–E) MPNSTs from mice that received NIF/− bone marrow showed similar levels of Ki67 staining as mice that received NIF/F bone marrow, but NIF/− MPNSTs were enriched in CD45+ cells. Scale bar is equal to 100 microns.